タンパク質キナーゼLYNによる肝臓の有機アニオン輸送ポリペプチド1B型輸送機能の調節
Vivian Xu1, Mahesh R Nepal2, Eman Ahmed2
1Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Division of Molecular Biosciences, University at Buffalo, Buffalo, New York.
Drug metabolism and disposition: the biological fate of chemicals
|September 3, 2025
まとめ
LYNキナーゼの減少は肝臓の吸収トランスポーターOatp1b2の活性を低下させ,薬物相互作用を引き起こす可能性があります. この研究は,LYN
科学分野:
- 薬理学について
- 生物化学
- 薬物の代謝
背景:
- LYNを含むSrcファミリーキナーゼは,薬物相互作用に関与するトランスポーターを調節する.
- LYNは肝細胞で発現し,肝臓の薬剤分泌に作用することを示唆している.
- LYN欠乏症は,トランスポーターのリン酸化と活性を変化させる可能性があります.
研究 の 目的:
- LYNが肝臓の薬物輸送を調節する役割を調査する.
- LYN欠乏がOatp1b2のリン酸化と活性に影響するかどうかを判断する.
- LYN媒介による薬剤相互作用の影響を調査する.
主な方法:
- ネズミの肝臓における非標的のフォスフォプロテオミクスクリーニング
- Oatp1b2を過剰発現する細胞と原始肝細胞を用いた細胞吸収アッセイ.
- LYNキナーゼ阻害剤ニロチニブまたはOatp1b阻害剤リファミンプシンで治療されたマウスでの薬理学研究
主要な成果:
- LYN欠乏症はOatp1b2のリン酸化と吸収活動を著しく低下させた.
- ニロチニブによるLYNキナーゼ抑制は,LYN欠乏の効果を模倣した.
- ニロチニブは,Oatp1b2基質のプラバスタチンの全身露出を増加させ,リファミシンに類似した.
- Oatp1b2欠乏したマウスでは,プラバスタチンの暴露に対するニロチニブの効果は認められなかった.
結論:
- LYNはOatp1b2に依存する肝臓吸収の主要な調節剤である.
- LYNキナーゼの活性障害は,薬物相互作用の新しいメカニズムを表しています.
- LYNの活性低下は,排泄輸送プロセスを無効化することによって,Oatp1bに依存する潜在的に危険な薬物相互作用につながる可能性があります.
関連する概念動画
Nonlinear Pharmacokinetics: Role of Transporters
91
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
91
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
79
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
79
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Hepatic Drug Clearance: Role of Transporters
100
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
100
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Drug Elimination by Renal Route: Tubular Secretion
2.5K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K


